H
Huaqing Shu
Researcher at Huazhong University of Science and Technology
Publications - 35
Citations - 8108
Huaqing Shu is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 22 publications receiving 5983 citations.
Papers
More filters
Journal ArticleDOI
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
Xiaobo Yang,Yuan Yu,Jiqian Xu,Huaqing Shu,Jia'an Xia,Hong Liu,Hong Liu,Yongran Wu,Lu Zhang,Zhui Yu,Minghao Fang,Ting Yu,Yaxin Wang,Shangwen Pan,Xiaojing Zou,Shiying Yuan,You Shang,You Shang +17 more
TL;DR: The clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia who were admitted to the intensive care unit (ICU) of Wuhan Jin Yin-tan hospital between late December, 2019 and Jan 26, 2020 are described.
Journal ArticleDOI
Maresin 1 prevents lipopolysaccharide-induced neutrophil survival and accelerates resolution of acute lung injury.
Jie Gong,Hong Liu,Jing Wu,Hong Qi,Zhou-Yang Wu,Huaqing Shu,Hongbin Li,Lin Chen,Yaxin Wang,Bo Li,Min Tang,Yu-dong Ji,Shiying Yuan,Shanglong Yao,You Shang +14 more
TL;DR: MaR1 promotes the resolution of L PS-induced ALI by overcoming LPS-mediated suppression of neutrophil apoptosis by overcoming the proapoptotic action of MaR1.
Journal ArticleDOI
Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
Huaqing Shu,Shuzhen Wang,Shunan Ruan,Yaxin Wang,Jiancheng Zhang,Yin Yuan,Hong Liu,Hong Liu,Yongran Wu,Yongran Wu,Ruiting Li,Shangwen Pan,Yaqi Ouyang,Shiying Yuan,Shiying Yuan,Peng Zhou,You Shang,You Shang +17 more
TL;DR: It is concluded that IgG could be a sensitive indicator for retrospective diagnosis and contact tracing, while IgM could be an indicator of early infection in COVID-19 infection.
Journal ArticleDOI
A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure
Jiqian Xu,Xiaobo Yang,Chaolin Huang,Xiaojing Zou,Ting Zhou,Shangwen Pan,Luyu Yang,Yongran Wu,Yaqi Ouyang,Yaxin Wang,Dan Xu,Xin Zhao,Huaqing Shu,Yongxiang Jiang,Wei Xiong,Lehao Ren,Hong Liu,Yin Yuan,Hong Qi,Shouzhi Fu,Dechang Chen,Dingyu Zhang,Shiying Yuan,You Shang +23 more
TL;DR: Aged patients with lower ROX index, thrombocytopenia, and elevated IL-6 values are at increased risk of HFNC failure, and early stratified COVID-19 patients with HFNC therapy into relevant risk categories are stratified.
Journal ArticleDOI
Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients.
Yuan Yu,Jie Tu,Bingxin Lei,Huaqing Shu,Xiaojing Zou,Ruiting Li,Chaolin Huang,Yali Qu,You Shang +8 more
TL;DR: This study revealed that a high number of patients with COVID-19 developed DVT, particularly in critically ill patients with high D-dimer levels who required no anticoagulant medication.